Skip to content

Rickettsial Genesis to Sarcoidosis in Denmark

Rickettsial Genesis to Sarcoidosis in Denmark

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00326534
Enrollment
36
Registered
2006-05-17
Start date
2006-09-30
Completion date
2009-03-31
Last updated
2009-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rickettsia Infections, Sarcoidosis

Keywords

Sarcoidosis, Rickettsia, Serological reactions, Polymerase chain reaction

Brief summary

One study has suggested a connection between an infection with Rickettsia species and sarcoidosis finding molecular evidence of rickettsial deoxyribonucleic acid (DNA) in two patients. Another study found no antibodies in twenty Swedish patients with sarcoidosis. This study will further enhance the subject by three different approaches in Danish patients. The purpose of this study is to find serological and molecular evidence of an infection with Rickettsia species in Danish patients with sarcoidosis.

Detailed description

The study has three approaches to the subject: 1. A serological survey of rickettsial immunoglobin G (IgG)-antibodies in 50 patients with sarcoidosis compared to 50 blood donors without sarcoidosis. 2. An archival study using pre-existing lymph node biopsies, where immunohistochemical analysis, fluorescent in situ hybridization, and polymerase chain reaction will be applied to samples from 50 patients with sarcoidosis and compared to 50 patients without sarcoidosis and 10 patients with tuberculosis. 3. A prospective study using bronchoscopically obtained samples from 20 patients with sarcoidosis, compared to 20 patients without sarcoidosis. The study applies the same techniques as the second study, but enhancing the information from the patients.

Interventions

None listed

Sponsors

Bispebjerg Hospital
CollaboratorOTHER
Civilingeniør Johs. E. Ormstrup og Hustru Grete Ormstrups Fond
CollaboratorUNKNOWN
Statens Serum Institut
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Referred to fiberoptic bronchoscopy in the department either because of sarcoidosis, hemoptysis, chronic cough, or cancer suspicion

Exclusion criteria

* Pregnant patients * Patients under the age of 18 * Patients without consent * Patients with a registered wish of not having their samples used for research

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026